These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 9622545)
21. Specific inhibition of human immunodeficiency virus type 1 reverse transcriptase mediated by soulattrolide, a coumarin isolated from the latex of calophyllum teysmannii. Pengsuparp T; Serit M; Hughes SH; Soejarto DD; Pezzuto JM J Nat Prod; 1996 Sep; 59(9):839-42. PubMed ID: 8864237 [TBL] [Abstract][Full Text] [Related]
22. Dipeptide alcohol-based inhibitors of eukaryotic DNA polymerase alpha. Kuriyama I; Asano N; Kato I; Ikeda K; Takemura M; Yoshida H; Sakaguchi K; Mizushina Y Bioorg Med Chem; 2005 Mar; 13(6):2187-96. PubMed ID: 15727871 [TBL] [Abstract][Full Text] [Related]
23. Investigating the effects of stereochemistry on incorporation and removal of 5-fluorocytidine analogs by mitochondrial DNA polymerase gamma: comparison of D- and L-D4FC-TP. Murakami E; Ray AS; Schinazi RF; Anderson KS Antiviral Res; 2004 Apr; 62(1):57-64. PubMed ID: 15026203 [TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of 2'-deoxy-5-styryluridine 5'-triphosphate analogs on retroviral reverse transcriptase and eukaryotic DNA polymerases. Yamaguchi T; Izuta S; Suzuki M; Yoshida S; Matsukage A; Saneyoshi M Nucleic Acids Symp Ser; 1992; (27):191-2. PubMed ID: 1283906 [TBL] [Abstract][Full Text] [Related]
25. Inhibitors of retroviral DNA polymerase: their implication in the treatment of AIDS. Chandra P; Vogel A; Gerber T Cancer Res; 1985 Sep; 45(9 Suppl):4677s-4684s. PubMed ID: 2410112 [TBL] [Abstract][Full Text] [Related]
26. Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon. Kramata P; Votruba I; Otová B; Holý A Mol Pharmacol; 1996 Jun; 49(6):1005-11. PubMed ID: 8649338 [TBL] [Abstract][Full Text] [Related]
27. Synthesis of AZT 5'-triphosphate mimics and their inhibitory effects on HIV-1 reverse transcriptase. Wang G; Boyle N; Chen F; Rajappan V; Fagan P; Brooks JL; Hurd T; Leeds JM; Rajwanshi VK; Jin Y; Prhavc M; Bruice TW; Cook PD J Med Chem; 2004 Dec; 47(27):6902-13. PubMed ID: 15615539 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of human immunodeficiency virus-1 reverse transcriptase activity by rubromycins: competitive interaction at the template.primer site. Goldman ME; Salituro GS; Bowen JA; Williamson JM; Zink DL; Schleif WA; Emini EA Mol Pharmacol; 1990 Jul; 38(1):20-5. PubMed ID: 1695317 [TBL] [Abstract][Full Text] [Related]
29. Recognition of structure of 5-halogenated derivatives of ara-UTP by DNA polymerase gamma and reverse transcriptase. Ono K; Ogasawara M; Ohashi A; Matsukage A; Takahashi T; Nakayama C; Saneyoshi M Nucleic Acids Symp Ser; 1979; (6):s129-32. PubMed ID: 94943 [TBL] [Abstract][Full Text] [Related]
30. Rational design of polymerase inhibitors as antiviral drugs. Oberg B Antiviral Res; 2006 Sep; 71(2-3):90-5. PubMed ID: 16820225 [TBL] [Abstract][Full Text] [Related]
31. 1-deoxyrubralactone, a novel specific inhibitor of families X and Y of eukaryotic DNA polymerases from a fungal strain derived from sea algae. Naganuma M; Nishida M; Kuramochi K; Sugawara F; Yoshida H; Mizushina Y Bioorg Med Chem; 2008 Mar; 16(6):2939-44. PubMed ID: 18178092 [TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of 1-beta-D-arabinofuranosylthymine 5'-triphosphate and 1-beta-D-arabinofuranosylcytosine 5'-triphosphate on DNA polymerases from murine cells and oncornavirus. Matsukage A; Ono K; Ohashi A; Takahashi T; Nakayama C; Saneyoshi M Cancer Res; 1978 Sep; 38(9):3076-9. PubMed ID: 79444 [TBL] [Abstract][Full Text] [Related]
33. L- and D-enantiomers of 2',3'-dideoxycytidine 5'-triphosphate analogs as substrates for human DNA polymerases. Implications for the mechanism of toxicity. Kukhanova M; Liu SH; Mozzherin D; Lin TS; Chu CK; Cheng YC J Biol Chem; 1995 Sep; 270(39):23055-9. PubMed ID: 7559445 [TBL] [Abstract][Full Text] [Related]
34. Penicilliols A and B, novel inhibitors specific to mammalian Y-family DNA polymerases. Kimura T; Takeuchi T; Kumamoto-Yonezawa Y; Ohashi E; Ohmori H; Masutani C; Hanaoka F; Sugawara F; Yoshida H; Mizushina Y Bioorg Med Chem; 2009 Mar; 17(5):1811-6. PubMed ID: 19223184 [TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of 1-beta-D-arabinofuranosyl-5-styryluracil 5'-triphosphates on DNA-dependent DNA polymerases alpha and beta from developing cherry salmon (Oncorhynchus masou) testes: on the approach to the selective affinity chromatography for DNA polymerase alpha. Izuta S; Saneyoshi M Nucleic Acids Symp Ser; 1984; (15):73-6. PubMed ID: 6522296 [TBL] [Abstract][Full Text] [Related]
36. Suramin affects DNA synthesis in HeLa cells by inhibition of DNA polymerases. Jindal HK; Anderson CW; Davis RG; Vishwanatha JK Cancer Res; 1990 Dec; 50(24):7754-7. PubMed ID: 2174730 [TBL] [Abstract][Full Text] [Related]
37. Epolactaene, a novel neuritogenic compound in human neuroblastoma cells, selectively inhibits the activities of mammalian DNA polymerases and human DNA topoisomerase II. Mizushina Y; Kobayashi S; Kuramochi K; Nagata S; Sugawara F; Sakaguchi K Biochem Biophys Res Commun; 2000 Jul; 273(2):784-8. PubMed ID: 10873681 [TBL] [Abstract][Full Text] [Related]
38. Strong and selective inhibitors of hepatitis B virus replication among novel N4-hydroxy- and 5-methyl-beta-L-deoxycytidine analogues. Matthes E; Funk A; Krahn I; Gaertner K; von Janta-Lipinski M; Lin L; Will H; Sirma H Antimicrob Agents Chemother; 2007 Jul; 51(7):2523-30. PubMed ID: 17404006 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of human immunodeficiency virus type 1 reverse transcriptase by the 5'-triphosphate beta enantiomers of cytidine analogs. Faraj A; Agrofoglio LA; Wakefield JK; McPherson S; Morrow CD; Gosselin G; Mathe C; Imbach JL; Schinazi RF; Sommadossi JP Antimicrob Agents Chemother; 1994 Oct; 38(10):2300-5. PubMed ID: 7530932 [TBL] [Abstract][Full Text] [Related]
40. De novo parallel design, synthesis and evaluation of inhibitors against the reverse transcriptase of human immunodeficiency virus type-1 and drug-resistant variants. Herschhorn A; Lerman L; Weitman M; Gleenberg IO; Nudelman A; Hizi A J Med Chem; 2007 May; 50(10):2370-84. PubMed ID: 17458947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]